Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram added to standard therapy for newly diagnosed glioblastoma
2013-004705-59Phase 3Completed
- Sponsor
- Erasmus Hospital
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of citalopram in glioblastoma (GBM) (2 arms), sponsored by Erasmus Hospital. Started Nov 2013; status: completed.
02
Drugs
citalopram
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2013-004705-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004705-59.